NTLA: Intellia Therapeutics Inc
NTLA exchange rate has changed by 5.04% for today. During the day, the instrument was traded at a low of 10.93 and at a high of 11.56.
Follow Intellia Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NTLA News
- 3 Promising Genomics Stocks to Add to Your Portfolio in 2026
- Intellia Therapeutics: An Overvalued Biotech With Little To No Commercial Potential (NTLA)
- Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable (PRME)
- NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?
- Wall Street Doubles Down on Wolfspeed Short Positions Over Cash Burn Fears
- Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?
- The Disinflation Trade Has A New Address: Genomics
- NTLA Posts Strong Additional Phase III Data From HAE Study, Stock Up
- Strength Seen in Intellia Therapeutics (NTLA): Can Its 23.2% Jump Turn into More Strength?
- Intellia Surges; Can Its Gene-Editing Drug Solve The Chronic Treatment Problem?
- Intellia Therapeutics (NTLA) Down 7.9% Since Last Earnings Report: Can It Rebound?
- Intellia Therapeutics Stock: Steady Progress, Historic Commercial Approval (NASDAQ:NTLA)
- ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?
- Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry?
- Cathie Wood trims $3.17M of surging bioscience stock
- Intellia Therapeutics, Inc. (NTLA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus
- Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Misses Revenue Estimates
Frequently Asked Questions
What is NTLA stock price today?
Intellia Therapeutics Inc stock is priced at 11.47 today. It trades within 10.93 - 11.56, yesterday's close was 10.92, and trading volume reached 6027. The live price chart of NTLA shows these updates.
Does Intellia Therapeutics Inc stock pay dividends?
Intellia Therapeutics Inc is currently valued at 11.47. Dividend policy depends on the company, while investors also watch -16.40% and USD. View the chart live to track NTLA movements.
How to buy NTLA stock?
You can buy Intellia Therapeutics Inc shares at the current price of 11.47. Orders are usually placed near 11.47 or 11.77, while 6027 and 3.71% show market activity. Follow NTLA updates on the live chart today.
How to invest into NTLA stock?
Investing in Intellia Therapeutics Inc involves considering the yearly range 7.95 - 18.48 and current price 11.47. Many compare -31.93% and -11.77% before placing orders at 11.47 or 11.77. Explore the NTLA price chart live with daily changes.
What are Intellia Therapeutics Inc stock highest prices?
The highest price of Intellia Therapeutics Inc in the past year was 18.48. Within 7.95 - 18.48, the stock fluctuated notably, and comparing with 10.92 helps spot resistance levels. Track Intellia Therapeutics Inc performance using the live chart.
What are Intellia Therapeutics Inc stock lowest prices?
The lowest price of Intellia Therapeutics Inc (NTLA) over the year was 7.95. Comparing it with the current 11.47 and 7.95 - 18.48 shows potential long-term entry points. Watch NTLA moves on the chart live for more details.
When did NTLA stock split?
Intellia Therapeutics Inc has gone through stock splits historically. These changes are visible in , 10.92, and -16.40% after corporate actions.
- Previous Close
- 10.92
- Open
- 11.06
- Bid
- 11.47
- Ask
- 11.77
- Low
- 10.93
- High
- 11.56
- Volume
- 6.027 K
- Daily Change
- 5.04%
- Month Change
- -31.93%
- 6 Months Change
- -11.77%
- Year Change
- -16.40%
- Act
- Fcst
- 1.978 M
- Prev
- -1.692 M
- Act
- Fcst
- 0.992 M
- Prev
- 0.430 M
- Act
- Fcst
- Prev
- 4.927%